NZ337589A - [1,4]diazepino[6,7,1-hi]indol-4-ones and there use in treating inflammatory diseases - Google Patents

[1,4]diazepino[6,7,1-hi]indol-4-ones and there use in treating inflammatory diseases

Info

Publication number
NZ337589A
NZ337589A NZ337589A NZ33758998A NZ337589A NZ 337589 A NZ337589 A NZ 337589A NZ 337589 A NZ337589 A NZ 337589A NZ 33758998 A NZ33758998 A NZ 33758998A NZ 337589 A NZ337589 A NZ 337589A
Authority
NZ
New Zealand
Prior art keywords
diazepino
indol
ones
inflammatory diseases
treating inflammatory
Prior art date
Application number
NZ337589A
Other languages
English (en)
Inventor
Yves Pascal
Catherine Burnouf
Bernard Gaudilliere
Henry Jacobelli
Alain Calvet
Adrian Payne
Svein Gunwald Dahl
Original Assignee
Parke Davis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis filed Critical Parke Davis
Publication of NZ337589A publication Critical patent/NZ337589A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NZ337589A 1997-04-30 1998-04-30 [1,4]diazepino[6,7,1-hi]indol-4-ones and there use in treating inflammatory diseases NZ337589A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9705422A FR2762841B1 (fr) 1997-04-30 1997-04-30 Diazepino-indolones inhibitrices de phosphodiesterases iv
PCT/EP1998/002827 WO1998049169A1 (en) 1997-04-30 1998-04-30 Phosphodiesterase 4-inhibiting diazepinoindolones

Publications (1)

Publication Number Publication Date
NZ337589A true NZ337589A (en) 2000-10-27

Family

ID=9506517

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ337589A NZ337589A (en) 1997-04-30 1998-04-30 [1,4]diazepino[6,7,1-hi]indol-4-ones and there use in treating inflammatory diseases

Country Status (17)

Country Link
US (1) US6239130B1 (https=)
EP (1) EP0980374B1 (https=)
JP (1) JP2001522367A (https=)
KR (1) KR20010020386A (https=)
AT (1) ATE232534T1 (https=)
AU (1) AU729495B2 (https=)
BR (1) BR9809429A (https=)
CA (1) CA2278217A1 (https=)
DE (1) DE69811360T2 (https=)
DK (1) DK0980374T3 (https=)
ES (1) ES2190083T3 (https=)
FR (1) FR2762841B1 (https=)
HR (1) HRP980231B1 (https=)
MX (1) MXPA99006979A (https=)
NZ (1) NZ337589A (https=)
WO (1) WO1998049169A1 (https=)
ZA (1) ZA983704B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795731B1 (fr) 1999-07-02 2001-09-07 Warner Lambert Co PROCEDE DE PREPARATION DE [1,4] DIAZEPINO [6,7,1-hi] INDOL-4-ONES SUBSTITUEES
AU2001232175B2 (en) * 2000-03-03 2005-07-07 Pfizer Products Inc. Pyrazole ether derivatives as anti-inflammatory/analgesic agents
EP1161949A1 (en) 2000-06-09 2001-12-12 Warner-Lambert Company Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease
EP1188438A1 (en) * 2000-09-15 2002-03-20 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production
EP1199074A1 (en) * 2000-09-15 2002-04-24 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production
ES2427930T3 (es) 2001-05-23 2013-11-04 Mitsubishi Tanabe Pharma Corporation Composición terapéutica para el tratamiento regenerativo de enfermedades de los cartílagos
KR20040007596A (ko) 2001-05-23 2004-01-24 다나베 세이야꾸 가부시키가이샤 골절 치료 촉진용 조성물
WO2003007955A2 (en) * 2001-07-20 2003-01-30 Cancer Research Technology Limited Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
WO2006073413A1 (en) * 2004-02-20 2006-07-13 The Board Of Trustees Of The University Of Illinois Blood pressure reduction in salt-sensitive
US20050239867A1 (en) * 2004-04-23 2005-10-27 Zeldis Jerome B Methods of using and compositions comprising PDE4 modulators for the treatment and management of pulmonary hypertension
NZ561746A (en) * 2005-04-19 2011-09-30 Nycomed Gmbh Roflumilast for the treatment of pulmonary hypertension
WO2008041118A2 (en) * 2006-10-04 2008-04-10 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
TW200902025A (en) * 2007-04-11 2009-01-16 Alcon Res Ltd Use of an inhibitor of TNF α plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
CN101784269A (zh) * 2007-06-26 2010-07-21 莱西肯医药有限公司 治疗由5-羟色胺介导的疾病和病症的方法
US20110082145A1 (en) * 2009-10-01 2011-04-07 Alcon Research, Ltd. Olopatadine compositions and uses thereof
NZ777336A (en) 2018-12-28 2026-02-27 Regeneron Pharma Treatment of respiratory disorders with arachidonate 15-lipoxygenase (alox15) inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2725719B1 (fr) * 1994-10-14 1996-12-06 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases iv

Also Published As

Publication number Publication date
DE69811360T2 (de) 2003-10-09
BR9809429A (pt) 2000-06-13
ZA983704B (en) 1999-10-25
WO1998049169A1 (en) 1998-11-05
EP0980374A1 (en) 2000-02-23
JP2001522367A (ja) 2001-11-13
DE69811360D1 (de) 2003-03-20
FR2762841A1 (fr) 1998-11-06
HRP980231B1 (en) 2002-06-30
KR20010020386A (ko) 2001-03-15
AU729495B2 (en) 2001-02-01
ATE232534T1 (de) 2003-02-15
HRP980231A2 (en) 2000-04-30
ES2190083T3 (es) 2003-07-16
AU7765298A (en) 1998-11-24
MXPA99006979A (es) 2005-04-19
CA2278217A1 (en) 1998-11-05
US6239130B1 (en) 2001-05-29
DK0980374T3 (da) 2003-05-05
FR2762841B1 (fr) 1999-07-02
EP0980374B1 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
NZ337589A (en) [1,4]diazepino[6,7,1-hi]indol-4-ones and there use in treating inflammatory diseases
HK1056165A1 (zh) 糖皮質激素選擇性抗炎劑
CA2289851A1 (en) Compounds and methods for the inhibition of the expression of vcam-1
HU9601790D0 (en) Diazabicyclic neurokinin antagonists
WO1996011266A3 (en) Method for inhibiting smooth muscle cell proliferation and oligonucleotides for use therein
IL119461A (en) 4,7-disubstituted -7H-pyrrolo ¬2, 3-d¾pyrimidines
EP0633775A4 (en) Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor.
WO2003041643A3 (en) Hsp90-inhibiting zearalanol compounds and methods of producing and using same
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
PL343018A1 (en) Glucocorticoid-selective anti-inflammatory agents
IL137509A0 (en) Glucocorticoid-selective anti-inflammatory agents
WO2001035950A3 (en) Benzamide therapeutics and methods for treating inflammatory bowel disease
WO2000074662A3 (en) Arthritis treatment
MY122278A (en) 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
IE873339L (en) 6-Benzoxazinyl- and¹6-benzothiazinyl-2,3,4,5-tetrahydropyridazin -3-ones.
NZ332096A (en) Alpha-hydroxylic acid derivatives their production and use in treating conditions requiring endothelin inhibition
NZ332834A (en) Glycosaminoglycan-related carbohydrate derivatives ( 5 saccharide groups ) having 4 to 6 sulphate groups
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
MXPA02012263A (es) 5-aminoalquil-pirazol[4,3-d]pirimidinas.
BG104292A (en) Methods and compositions for the treatment of rheumatoid arthritis
AU3539795A (en) Methods of treating cold symptoms using pentoxifylline
MXPA02012260A (es) 2-aminoalquil-tieno[2,3-d]pirimidinas.
IL143304A0 (en) The use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence
SI0912568T1 (en) Imidazopyridines
AU6107999A (en) 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)